These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E; Ahlquist D; Ullrich S; Gross WL Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Russell KA; Fass DN; Specks U Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478 [TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067 [TBL] [Abstract][Full Text] [Related]
5. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. Baslund B; Petersen J; Permin H; Wiik A; Wieslander J J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650 [TBL] [Abstract][Full Text] [Related]
6. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Daouk GH; Palsson R; Arnaout MA Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222 [TBL] [Abstract][Full Text] [Related]
9. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis]. Csernok E; Reichel P; Gross WL Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842 [TBL] [Abstract][Full Text] [Related]
10. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764 [TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324 [TBL] [Abstract][Full Text] [Related]
12. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537 [TBL] [Abstract][Full Text] [Related]
14. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030 [TBL] [Abstract][Full Text] [Related]
15. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Radice A; Vecchi M; Bianchi MB; Sinico RA Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394 [TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736 [TBL] [Abstract][Full Text] [Related]
18. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909 [TBL] [Abstract][Full Text] [Related]
19. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Muller Kobold AC; van Wijk RT; Franssen CF; Molema G; Kallenberg CG; Tervaert JW Clin Exp Rheumatol; 1999; 17(4):433-40. PubMed ID: 10464553 [TBL] [Abstract][Full Text] [Related]
20. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]